362 related articles for article (PubMed ID: 8168958)
1. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.
Probert WS; LeFebvre RB
Infect Immun; 1994 May; 62(5):1920-6. PubMed ID: 8168958
[TBL] [Abstract][Full Text] [Related]
2. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.
Luke CJ; Huebner RC; Kasmiersky V; Barbour AG
Vaccine; 1997; 15(6-7):739-46. PubMed ID: 9178476
[TBL] [Abstract][Full Text] [Related]
3. Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi.
Probert WS; Crawford M; Cadiz RB; LeFebvre RB
J Infect Dis; 1997 Feb; 175(2):400-5. PubMed ID: 9203661
[TBL] [Abstract][Full Text] [Related]
4. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
[TBL] [Abstract][Full Text] [Related]
6. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.
Ma J; Bulger PA; Davis DR; Perilli-Palmer B; Bedore DA; Kensil CR; Young EM; Hung CH; Seals JR; Pavia CS
Vaccine; 1994 Aug; 12(10):925-32. PubMed ID: 7975834
[TBL] [Abstract][Full Text] [Related]
7. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC.
Zhong W; Gern L; Stehle T; Museteanu C; Kramer M; Wallich R; Simon MM
Eur J Immunol; 1999 Mar; 29(3):946-57. PubMed ID: 10092099
[TBL] [Abstract][Full Text] [Related]
8. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
Schaible UE; Wallich R; Kramer MD; Gern L; Anderson JF; Museteanu C; Simon MM
Vaccine; 1993; 11(10):1049-54. PubMed ID: 8212826
[TBL] [Abstract][Full Text] [Related]
9. Selection of variant Borrelia burgdorferi isolates from mice immunized with outer surface protein A or B.
Fikrig E; Tao H; Barthold SW; Flavell RA
Infect Immun; 1995 May; 63(5):1658-62. PubMed ID: 7729870
[TBL] [Abstract][Full Text] [Related]
10. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA
J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061
[TBL] [Abstract][Full Text] [Related]
11. Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B.
Fikrig E; Tao H; Kantor FS; Barthold SW; Flavell RA
Proc Natl Acad Sci U S A; 1993 May; 90(9):4092-6. PubMed ID: 7683420
[TBL] [Abstract][Full Text] [Related]
12. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA.
Fikrig E; Barthold SW; Kantor FS; Flavell RA
Science; 1990 Oct; 250(4980):553-6. PubMed ID: 2237407
[TBL] [Abstract][Full Text] [Related]
13. Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines.
Telford SR; Fikrig E; Barthold SW; Brunet LR; Spielman A; Flavell RA
J Exp Med; 1993 Aug; 178(2):755-8. PubMed ID: 8340764
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB.
Hughes CA; Engstrom SM; Coleman LA; Kodner CB; Johnson RC
Infect Immun; 1993 Dec; 61(12):5115-22. PubMed ID: 8225588
[TBL] [Abstract][Full Text] [Related]
15. Oral Immunization with OspC Does Not Prevent Tick-Borne Borrelia burgdorferi Infection.
Melo R; Richer L; Johnson DL; Gomes-Solecki M
PLoS One; 2016; 11(3):e0151850. PubMed ID: 26990760
[TBL] [Abstract][Full Text] [Related]
16. Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins.
Bunikis J; Barbour AG
Infect Immun; 1999 Jun; 67(6):2874-83. PubMed ID: 10338494
[TBL] [Abstract][Full Text] [Related]
17. Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.
Shang ES; Champion CI; Wu XY; Skare JT; Blanco DR; Miller JN; Lovett MA
Infect Immun; 2000 Jul; 68(7):4189-99. PubMed ID: 10858236
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype.
Wilske B; Jauris-Heipke S; Lobentanzer R; Pradel I; Preac-Mursic V; Rössler D; Soutschek E; Johnson RC
J Clin Microbiol; 1995 Jan; 33(1):103-9. PubMed ID: 7699024
[TBL] [Abstract][Full Text] [Related]
19. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
LaFleur RL; Dant JC; Wasmoen TL; Callister SM; Jobe DA; Lovrich SD; Warner TF; Abdelmagid O; Schell RF
Clin Vaccine Immunol; 2009 Feb; 16(2):253-9. PubMed ID: 19052162
[TBL] [Abstract][Full Text] [Related]
20. Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis.
Dunne M; al-Ramadi BK; Barthold SW; Flavell RA; Fikrig E
Infect Immun; 1995 Apr; 63(4):1611-4. PubMed ID: 7890431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
